AnalyzeDirect Shah M, Law JH, Micheletto F, Sathananthan M, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Zinsmeister AR, Vella A. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes. February 2014;63(2):483-493.
Full Text – Open Access
Publication Date
February 2014
How Analyze was Used
“A region of interest analysis around the stomach or, in the case of RYGB subjects, around the gastric pouch was created using ANALYZE PC 2.5…, and the counts in the stomach and their change over time were quantitated. The counts were corrected for radionuclide decay and tissue attenuation.”
Keywords
Case-Control Studies
Female
Gastric Bypass
Gene Expression Regulation
Glucagon-Like Peptide 1/antagonists & inhibitors/genetics/metabolism
Glucose/metabolism
Humans
Male
Peptide Fragments/pharmacology
Author Affiliation(s)
Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic College of Medicine, Rochester, MN, US. (MS, JHL, MS, RAR, AV)
Department of Information Engineering, University of Padua, Padua, Italy. (FM, CDM, CC)
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, US. (MC)
Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN, US. (ARZ)
ID# 84
Tags: Case-Control Studies, Female, Gastric Bypass, Gene Expression Regulation, Glucagon-Like Peptide 1/antagonists & inhibitors/genetics/metabolism, Glucose/metabolism, Humans, Male, Peptide Fragments/pharmacology